Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
33.3%
% of IDNA's 49 holdings also in CANC
31.9%
% of CANC's 47 holdings also in IDNA
Overlap by Weight
Sector Drift (IDNA minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IDNA |
Weight in CANC |
Overlap | |
---|---|---|---|---|
GILEAD SCIENCES INC | 5.7% | 5.4% | 5.4% | |
REVOLUTION MEDICINES, INC. | 5.7% | 4.6% | 4.6% | |
INCYTE CORP | 5.0% | 4.2% | 4.2% | |
EXELIXIS INC | 6.6% | 3.0% | 3.0% | |
REGENERON PHARMACEUTICALS | 3.0% | 5.4% | 3.0% |
Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to CANC
BEIGENE, LTD. | 5.4% | |
SAREPTA THERAPEUTICS INC | 4.3% | |
ROCHE HOLDING LTD | 4.3% | |
TAKEDA PHARMACEUTICAL CO LTD | 4.0% | |
SANOFI-AVENTIS | 4.0% | |
BIONTECH SE SPONSORED ADR | 3.7% | |
EXELIXIS INC | 3.6% | |
GSK PLC | 3.2% | |
GENMAB A/S | 3.1% | |
TWIST BIOSCIENCE CORP. | 3.0% |
IDNA Underweight Relative to CANC
ASTRAZENECA PLC | -5.2% | |
ARGENX SE ADR | -4.3% | |
ILLUMINA INC | -3.8% | |
CHUGAI PHARMACEUTICAL CO LTD | -3.3% | |
DAIICHI SANKYO CO LTD | -3.1% | |
BLUEPRINT MEDICINES CORP. | -2.9% | |
AGIOS PHARMACEUTICALS INC | -2.9% | |
BEIGENE LTD. SPONSORED ADR | -2.5% | |
REGENERON PHARMACEUTICALS | -2.4% | |
GUARDANT HEALTH, INC. | -2.4% |